Zimmer Biomet’s diagnostic offerings are focused on developing novel biomarkers and tests to support diagnosis of a number of conditions related to joint pain, including commercially available Periprosthetic Joint Infection (PJI) lateral flow. With the addition of the diagnostics portfolio, Zimmer Biomet continues to drive their commitment to providing patients and surgeons with a complete continuum of care solution for joint pain.